Red blood cell pathologies were highlighted during the congress. In particular, the Topics-in-Focus program put the spotlight on haemoglobinopathies. As in oncology, these heterogeneous (very) rare diseases also benefit from new tools for their diagnosis and from new or evolving therapies. Gene therapy is probably the most exciting one as it represents a curative approach.
(BELG J HEMATOL 2018;9(4):161–3)
* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Hematology in Belgium and Luxembourg with prescription authorisation)
** (for healthcare professionals with prescribing authorisation working outside the field of Hematology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Hematology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)
Top
